NEU 3.26% $21.09 neuren pharmaceuticals limited

Share Price

  1. 2,282 Posts.
    lightbulb Created with Sketch. 1821
    I think the current share price is ridiculous for the following reasons .
    1. Current capitalisation of the company is $233 million
    2. The company would have about $35 million in the bank .
    3. So the other assets are valued by the market $198 million ,that is for 6 indications with nnz2566 and nnz2591 .
    4. The trial results for trofinetide should be due in less than 8 weeks .
    5. If trofinetide is successful the share price should be between $4 and $5 dollars.
    6. The results only need to mirror Phase 2 results to be successful .
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$21.09
Change
-0.710(3.26%)
Mkt cap ! $2.693B
Open High Low Value Volume
$21.74 $21.78 $21.03 $7.303M 342.4K

Buyers (Bids)

No. Vol. Price($)
1 377 $21.08
 

Sellers (Offers)

Price($) Vol. No.
$21.10 257 1
View Market Depth
Last trade - 16.10pm 17/05/2024 (20 minute delay) ?
Last
$21.16
  Change
-0.710 ( 3.28 %)
Open High Low Volume
$21.72 $21.72 $21.03 92331
Last updated 15.59pm 17/05/2024 ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.